Lilian Toledo

Lilian Toledo

Auto-generated profile, based on publicly available information

Lilian Toledo

Laboratory of Autophagy and Metabolism, Department of Physiology, Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2019 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
MHMaría Paz Hernández-Cáceres
María Paz Hernández-Cáceres
LTLilian Toledo-Valenzuela
Lilian Toledo-Valenzuela
Francisco Díaz-CastroFrancisco Díaz-Castro
Francisco Díaz-Castro
YÁYenniffer Ávalos
Yenniffer Ávalos
PBPaulina Burgos
Paulina Burgos
EMEugenia Morselli
Eugenia Morselli
Chronic consumption of high fat diets (HFDs), rich in saturated fatty acids (SatFAs) like palmitic acid (PA), is associated with the development of obesity and obesity-related metabolic diseases such as type II diabetes mellitus (T2DM). Previous studies indicate that PA accumulates in the hypothalamus following consumption of HFDs; in addition, HFDs consumption inhibits autophagy and reduces insulin sensitivity. Whether malfunction of autophagy specifically in hypothalamic neurons decreases insulin sensitivity remains unknown. PA does activate the Free Fatty Acid Receptor 1 (FFAR1), also known as G protein-coupled receptor 40 (GPR40); however, whether FFAR1 mediates the effects of PA on hypothalamic autophagy and insulin sensitivity has not been shown. Here, we demonstrate that exposure to PA inhibits the autophagic flux and reduces insulin sensitivity in a cellular model of hypothalamic neurons (N43/5 cells). Furthermore, we show that inhibition of autophagy and the autophagic flux reduces insulin sensitivity in hypothalamic neuronal cells. Interestingly, the inhibition of the autophagic flux, and the reduction in insulin sensitivity are prevented by pharmacological inhibition of FFAR1. Our findings show that dysregulation of autophagy reduces insulin sensitivity in hypothalamic neuronal cells. In addition, our data suggest FFAR1 mediates the ability of PA to inhibit autophagic flux and reduce insulin sensitivity in hypothalamic neuronal cells. These results reveal a novel cellular mechanism linking PA-rich diets to decreased insulin sensitivity in the hypothalamus and suggest that hypothalamic autophagy might represent a target for future T2DM therapies.

31 March 2016 in Frontiers in Physiology
Verified
Journal Article
Open access
Luis SobreviaLuis Sobrevia
Luis Sobrevia
RSRocío Salsoso
Rocío Salsoso
BFBárbara Fuenzalida
Bárbara Fuenzalida
Eric BarrosEric Barros
Eric Barros
LTLilian Toledo
Lilian Toledo
ALAndrea Leiva
Andrea Leiva
Gestational diabetes mellitus (GDM) is a disease of the mother that associates with altered fetoplacental vascular function. GDM–associated maternal hyperglycaemia result in fetal hyperglycaemia, a condition that leads to fetal hyperinsulinemia and altered L-arginine transport and synthesis of nitric oxide, i.e., endothelial dysfunction. These alterations in the fetoplacental endothelial function are present in women with GDM that were under diet or insulin therapy. Since these women and their newborn show normal glycaemia at term, other factors or conditions could be altered and/or not resolved by restoring a normal level of circulating D-glucose. GDM associates with metabolic disturbances, such as abnormal handling of the locally released vasodilator adenosine, and biosynthesis and metabolism of cholesterol lipoproteins, or metabolic diseases resulting in endoplasmic reticulum stress and altered angiogenesis. Insulin acts as a potent modulator of all these phenomena under normal conditions as reported in primary cultures of cells obtained from the human placenta; however, GDM and the role of insulin regarding these alterations in this disease are poorly understood. This review focuses on the potential link between insulin and endoplasmic reticulum stress, hypercholesterolemia, and angiogenesis in GDM in the human fetoplacental vasculature. Based in reports in primary culture placental endothelium we propose that insulin is a factor restoring endothelial function in GDM by reversing ERS, hypercholesterolaemia and angiogenesis to a physiological state involving insulin activation of insulin receptor isoforms and adenosine receptors and metabolism in the human placenta from GDM pregnancies.

25 July 2020 in Molecular & Cellular Oncology
Verified
Journal Article
Closed access
MHMaría Paz Hernández-Cáceres
María Paz Hernández-Cáceres
KCKarina Cereceda
Karina Cereceda
SHSergio Hernández
Sergio Hernández
YLYing Li
Ying Li
CNCarla Narro
Carla Narro
EMEugenia Morselli
Eugenia Morselli
High-fat diet (HFD)-induced obesity is associated with increased cancer risk. Long-term feeding with HFD increases the concentration of the saturated fatty acid palmitic acid (PA) in the hypothalamus. We previously showed that, in hypothalamic neuronal cells, exposure to PA inhibits the autophagic flux, which is the whole autophagic process from the synthesis of the autophagosomes, up to their lysosomal fusion and degradation. However, the mechanism by which PA impairs autophagy in hypothalamic neurons remains unknown. Here, we show that PA-mediated reduction of the autophagic flux is not caused by lysosomal dysfunction, as PA treatment does not impair lysosomal pH or the activity of cathepsin B.Instead, PA dysregulates autophagy by reducing autophagosome-lysosome fusion, which correlates with the swelling of endolysosomal compartments that show areduction in their dynamics. Finally, because lysosomes undergo constant dynamic regulation by the small Rab7 GTPase, we investigated the effect of PA treatment on its activity. Interestingly, we found PA treatment altered the activity of Rab7. Altogether, these results unveil the cellular process by which PA exposure impairs the autophagic flux. As impaired autophagy in hypothalamic neurons promotes obesity, and balanced autophagy is required to inhibit malignant transformation, this could affect tumor initiation, progression, and/or response to therapy of obesity-related cancers.

1 March 2016 in Pharmacological Research
Verified
Journal Article
Closed access
CSCarlos Sanhueza
Carlos Sanhueza
JAJoaquín Araos
Joaquín Araos
LNLuciano Naranjo
Luciano Naranjo
Eric BarrosEric Barros
Eric Barros
LTLilian Toledo
Lilian Toledo
Luis SobreviaLuis Sobrevia
Luis Sobrevia

1 January 2017
Verified
Book Chapter
Closed access
YÁYenniffer Ávalos
Yenniffer Ávalos
MHMaría Paz Hernández-Cáceres
María Paz Hernández-Cáceres
LTLilian Toledo
Lilian Toledo
EMEugenia Morselli
Eugenia Morselli